US 11617801
RP2 and RPGR vectors for treating X-linked retinitis pigmentosa
granted A61KA61K38/1709A61K48/005
Quick answer
US patent 11617801 (RP2 and RPGR vectors for treating X-linked retinitis pigmentosa) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Mar 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Apr 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K38/1709, A61K48/005, A61K48/0058, A61P